Category: Covid-19
-
Weekly respiratory virus update, week 4, January 2025
There is currently significant respiratory virus activity in the EU/EEA, with both influenza and RSV epidemics ongoing. Vaccination campaigns against respiratory pathogens continue in many EU/EEA countries, and people who are eligible for vaccination are encouraged to get vaccinated.
-
Weekly respiratory virus update, week 3, January 2025
There is currently significant respiratory virus activity in the EU/EEA, with both influenza and RSV epidemics ongoing. Vaccination campaigns against respiratory pathogens continue in many EU/EEA countries and people who are eligible for vaccination are encouraged to get vaccinated.
-
Reporting protocol for zoonotic influenza virus
This reporting protocol describes data collection for human cases of zoonotic influenza viruses, with the aim to support assessment of key indicators and trends over time and inform situational risk assessments.
-
Zoonotic influenza virus Reporting protocol Version 2.4
This reporting protocol describes data collection for human cases of zoonotic influenza viruses, with the aim to support assessment of key indicators and trends over time and inform situational risk assessments.
-
Weekly respiratory virus update, week 2, January 2025
At the EU/EEA level, influenza activity continues to increase while RSV activity is decreasing. Vaccination campaigns against respiratory pathogens continue in many EU/EEA countries and people who are eligible for vaccination, particularly those at higher risk of severe outcomes, are encouraged to get vaccinated.
-
Communicable disease threats report, 11 – 17 January 2025, week 3
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11 – 17 January 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, mpox, influenza, cholera, Marburg virus, rabies, and chikungunya, measles, polio, MRSA, and mass gathering monitoring for the Jubilee of 2025 in Italy.
-
Weekly respiratory virus update, week 1, January 2025
In the EU/EEA, both influenza and RSV activity is increasing.
-
Weekly respiratory virus update, week 50, December 2024
In the EU/EEA, both influenza and RSV epidemics are ongoing in several countries. Vaccination campaigns against respiratory pathogens have started in many EU/EEA countries. People who are eligible for vaccination, particularly those at higher risk of severe outcomes, are encouraged to get vaccinated.
-
Increase in respiratory infections in China
The Chinese Centre for Disease Control and Prevention (CDC) has reported a sharp increase in respiratory viral infections, including human metapneumovirus (hMPV) infections, in northern China since December 2024.